000 01173 a2200337 4500
005 20250515103655.0
264 0 _c20080229
008 200802s 0 0 eng d
022 _a0013-9580
024 7 _a10.1111/j.1528-1167.2008.01446.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChadwick, David W
245 0 0 _aThe treatment of the first seizure: the benefits.
_h[electronic resource]
260 _bEpilepsia
_c2008
300 _a26-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aActuarial Analysis
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aCarbamazepine
_xtherapeutic use
650 0 4 _aEpilepsy
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aPhenobarbital
_xtherapeutic use
650 0 4 _aPrognosis
650 0 4 _aRandomized Controlled Trials as Topic
_xstatistics & numerical data
650 0 4 _aRisk Assessment
650 0 4 _aSecondary Prevention
650 0 4 _aTreatment Outcome
650 0 4 _aValproic Acid
_xtherapeutic use
773 0 _tEpilepsia
_gvol. 49 Suppl 1
_gp. 26-8
856 4 0 _uhttps://doi.org/10.1111/j.1528-1167.2008.01446.x
_zAvailable from publisher's website
999 _c17693944
_d17693944